Pubblicato il 10/01/2017
Tipo di Laurea: Economia, Ingegneria Gestionale
If you want to be a part of innovative projects with real impact on the business, please apply for:
Philip Morris Italia YES INTERNSHIP PROGRAM
Business Analyst – Reduced Risk Products Department[*]
We offer:
- Internship of 6 months length
- International and fast-paced work environment in a constantly evolving industry
- Opportunity to learn more by interacting with dynamic teams at different levels of experience and expertise across the Company
- Onboarding program; on-the-job & off-the-job Trainings
You will support the Reduced Risk Product Department in:
- Keeping corporate and local systems updated
- Answering department-related ad-hoc queries
- Assessing the accuracy of data provided by 3rd parties
- Preparing corporate and local reports and presentations to management
- Monitoring economic indicators and macroeconomic trends
- Tracking System.
- Planning
- Project Management.
You have:
- University degree in: Management Engineering, Business Administration or Economics
- Communication skills
- Good analytical skills and passion for data interpretation and quantitative analysis
- Quick learning capabilities entrepreneurial spirit and curiosity
- Problem solving and customer orientation
- Ability to work alone and in teams
- Fluent in English and Fluent in Italian
- Literacy in Word, Excel and PowerPoint (Access as a plus)
- Previous experience in other Company is a plus
Place of employment: Rome
A reimbursement package (monthly stage bonus + ticket restaurant) is provided.
Come and discover the world of Philip Morris International!
Ready to take this opportunity? Interested? Motivated? Apply on-line: www.pmicareers.com
[*]Reduced-Risk Products (“RRPs”) is the term the Company uses to refer to products with the potential to reduce individual risk and population harm in comparison to smoking combustible cigarettes. PMI’s RRPs are in various stages of development and we are conducting extensive and rigorous scientific studies to determine whether we can support claims for such products of reduced exposure to harmful and potentially harmful constituents in smoke, and ultimately claims of reduced disease risk, when compared to smoking combustible cigarettes. Before making any such claims, we will need to rigorously evaluate the full set of data from the relevant scientific studies to determine whether they substantiate reduced exposure or risk. Any such claims may also be subject to government review and approval, as is the case in the United States today.